ArticleMolecular cancer therapeutics2018

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.

Shanthi Ganesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.